Bio-labs expands international operations

Bio-Labs expands international operations into CIS countries by commencing regulatory registrations in several therapeutic categories.

Fusidic Acid, Betamethasone & Hydrocortisone.

A new range of dermatology products under the brand name of BUSID CREAM are launched including Fusidic Acid, Betamethasone & Hydrocortisone for better skin infections treatment.

Bio-Labs launches BIO-D3

Bio-Labs launches BIO-D3, a new range of Vitamin D3 products including dosage forms in liquid ampoules, tablets and drops.

Kenya Pharmacy & Poison Board (PPB)

Kenya Pharmacy & Poison Board (PPB) grants Good Manufacturing Practices license to Bio-Labs after successful plant inspection allowing further market expansion in the African continent.